VBI Vaccines | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Perceptive Advisors LLC(4.4%),Joseph Edelman(4.4%), etc.
Apr 17 16:21 ET
VBI Vaccines | 10-K: Annual report
Apr 16 08:05 ET
VBI Vaccines | 8-K: Current report
Apr 16 08:05 ET
VBI Vaccines | 8-K: Current report
Apr 11 16:12 ET
VBI Vaccines | 424B5: Prospectus
Apr 11 09:09 ET
VBI Vaccines | 8-K: Current report
Apr 3 08:02 ET
VBI Vaccines | 8-K: Current report
Apr 2 08:04 ET
VBI Vaccines | NT 10-K: Others
Mar 28 16:21 ET
VBI Vaccines | 8-K: Current report
Feb 14 08:36 ET
VBI Vaccines | 8-K: Current report
Feb 6 16:28 ET
VBI Vaccines | 8-K: Current report
Jan 23 00:00 ET
VBI Vaccines | 8-K: Current report
Jan 11 00:00 ET
VBI Vaccines | 8-K: Current report
Dec 26, 2023 00:00 ET
VBI Vaccines | 8-K: Current report
Dec 12, 2023 16:15 ET
VBI Vaccines | 8-K: Current report
Nov 29, 2023 16:15 ET
VBI Vaccines | 8-K: Current report
Nov 20, 2023 08:00 ET
VBI Vaccines | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Perceptive Advisors LLC(5.8%),Joseph Edelman(5.8%), etc.
Nov 17, 2023 18:59 ET
VBI Vaccines | 8-K: VBI Vaccines Reports Third Quarter 2023 Financial Results
Nov 14, 2023 16:07 ET
VBI Vaccines: Q3 2023 Earnings Report
Nov 14, 2023 16:06 ET
VBI Vaccines | 8-K: Current report
Nov 3, 2023 17:00 ET
No Data
No Data